Similar articles

• Polyunsaturated fatty acids and colchicine in multiple sclerosis.

  Horrobin DF, Botez T, Botez MI. Horrobin DF, et al. Br Med J. 1979 Jan 20;1(6157):199-200. doi: 10.1136/bmj.1.6157.199-d. Br Med J. 1979. PMID: 421025 Free PMC article. No abstract available.
• Polyunsaturated fatty acids and colchicine in multiple sclerosis.

  [No authors listed] [No authors listed] Br Med J. 1979 Feb 10;1(6160):411-2. doi: 10.1136/bmj.1.6160.411-a. Br Med J. 1979. PMID: 761034 Free PMC article. No abstract available.
• Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.

  Bates D, Fawcett PR, Shaw DA, Weightman D. Bates D, et al. Br Med J. 1977 Oct 8;2(6092):932-3. doi: 10.1136/bmj.2.6092.932-a. Br Med J. 1977. PMID: 334337 Free PMC article. Clinical Trial. No abstract available.
• Supplementation of polyunsaturated fatty acids in multiple sclerosis.

  Gallai V, Sarchielli P, Trequattrini A, Murasecco D. Gallai V, et al. Ital J Neurol Sci. 1992 Jun;13(5):401-7. doi: 10.1007/BF02312146. Ital J Neurol Sci. 1992. PMID: 1517064 Review.
• [Polyunsaturated fatty acids for multiple sclerosis treatment: scientific evidence].

  Kong-González M, Pérez-Cortéz JG, Hernández-Girón C, Macías-Morales N, Flores-Aldana M. Kong-González M, et al. Medwave. 2015 Jan 7;15(1):e6062. doi: 10.5867/medwave.2015.01.6062. Medwave. 2015. PMID: 25628005 Review. Spanish.